Needham & Company downgraded Cepheid (NASDAQ: CPHD) from Buy to Hold.Analyst Mike Matson commented, "CPHD's 3Q15 results were consistent with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE